Skip to main content
Clinical Trials/NCT02093013
NCT02093013
Completed
Not Applicable

Impact of an Integrated Care Intervention Program on Asthmatic Patients.

Laval University1 site in 1 country349 target enrollmentMay 2004
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Laval University
Enrollment
349
Locations
1
Primary Endpoint
Asthma control
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The investigators propose to implement and evaluate an integrated care program for enhancing the care of patients with asthma in a region of Quebec province, Canada. The investigators will implement our intervention in a family medicine group practice setting and plan to deliver it to 150 experimental group subjects. The investigators will simultaneously study 300 control subjects who are receiving usual care in other regions of the province of Quebec. Our hypothesis is that the program will improve the quality of life of patients with asthma exposed to the program, asthma control, inhaled corticosteroid adherence, knowledge of asthma, and a number of variables that relate to the conceptual model selected as a framework for this study (the PRECEDE-PROCEED model of Green and Kreuter).

Registry
clinicaltrials.gov
Start Date
May 2004
End Date
July 2007
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Line Guénette

Co-investigator

Laval University

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 12 to 45 years, for whom the pharmacists had dispensed at least one anti-asthma drug in the previous six months were screened and randomly contacted by phone. Those who reported an asthma diagnosis and who were using a short-acting beta-2-agonist (SABA) \>3 times a week (except before exercise) or a corticosteroid (inhaled or oral), irrespective of frequency were included.

Exclusion Criteria

  • Pregnancy, no prior asthma diagnosis, participation in an ongoing respiratory study, or another respiratory illness.

Outcomes

Primary Outcomes

Asthma control

Time Frame: One year

The primary outcome was asthma control, measured with the validated Asthma Control Questionnaire.

Secondary Outcomes

  • Adherence to ICS(One year)

Study Sites (1)

Loading locations...

Similar Trials